<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117748">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02013869</url>
  </required_header>
  <id_info>
    <org_study_id>201301</org_study_id>
    <secondary_id>JJ201301</secondary_id>
    <nct_id>NCT02013869</nct_id>
  </id_info>
  <brief_title>Low Flow Anaesthesia</brief_title>
  <acronym>LF</acronym>
  <official_title>Low Flow Anaesthesia; Cost-effectiveness of the Flow-I Anaesthesia Machine, a Comparison to Established Anaesthesia Delivery Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jan Jakobsson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <authority>Sweden: Medical Products Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the Flow-I breathing circle during low flow general anaesthesia, whether this
      non-below system has advantages reduced time to reach Et 1MAC (minimal alveolar
      concentration) and lower consumption of inhaled agent
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assessing whether there are clinical differences in anaesthetic performance between standard
      anaesthesia workstation including a below and the new Flow-I device without a below
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Time to reach 1.5 MAC (minimal alveolar concentration) Et</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>The time needed, seconds, to increase the end tidal desflurane concentration during wash-in from a 1 MAC to a 1.5 MAC with a constant fresh gas flow of 1 L/min and the vaporiser set a 3 MAC ( minimal alveolar concentration) (18%) will be compared between the two study groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>amount of inhaled agent consumed ml/min</measure>
    <time_frame>5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The vaporiser will be weighed before and after each case and the amount of vapor, desflurane, consumed during the anaesthesia will be calculated Gr/min.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Quality of Recovery</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of recovery will be followed during the first 72 hours after anaesthesia</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adequate anaesthesia</measure>
    <time_frame>5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients will be asked after end of anaesthesia if they have had any recall of intraoperative events</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>General Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Flow-I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wash in of desflurane in an anaesthesia machine without below</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asys</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wash in of desflurane in conventional anaesthesia machine Asys</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flow-I</intervention_name>
    <description>Desflurane Dialed setting 18 %</description>
    <arm_group_label>Flow-I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Asys</intervention_name>
    <description>Desflurane dialed 18%</description>
    <arm_group_label>Asys</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ASA 1-2 patient 18 - 65 years scheduled for elective surgery

        Exclusion Criteria:

        ASA &gt; 2 heart failure COPD
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan g Jakobsson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan g Jakobsson, MD</last_name>
    <phone>46 70 250 09 60</phone>
    <email>jan.jakobsson@ki.se</email>
  </overall_contact>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>November 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Jan Jakobsson</investigator_full_name>
    <investigator_title>Adj Professor</investigator_title>
  </responsible_party>
  <keyword>fresh gas flow</keyword>
  <keyword>quality of anaesthesia</keyword>
  <keyword>minimal alveolar concentration</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
